Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab. - Rossi, S.; Motta, C.; Studer, V.; De Chiara, V.; Barbieri, F.; Monteleone, F.; Fornasiero, A.; Coarelli, G.; Bernardi, G.; Cutter, G.; Stüve, O.; Salvetti, M.; et al. (European Journal of Neurology, 2013)